WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Stock Ownership - Who owns Blueprint Medicines?

Insider buying vs selling

Have Blueprint Medicines Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2024-05-154,500$36.05
$162.23kBuy
Michael LandsittelCHIEF FINANCIAL OFFICER2024-05-152,486$107.17
$266.42kSell
Michael LandsittelCHIEF FINANCIAL OFFICER2024-05-151,364$106.56
$145.35kSell
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2024-05-152,274$106.56
$242.32kSell
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2024-05-153,582$107.22
$384.06kSell
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2024-05-151,356$43.15
$58.51kBuy
Michael LandsittelCHIEF FINANCIAL OFFICER2024-05-081,818$8.80
$16.00kBuy
Michael LandsittelCHIEF FINANCIAL OFFICER2024-05-0826,363$1.87
$49.30kBuy
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2024-05-021,834$54.13
$99.27kBuy
Michael LandsittelCHIEF FINANCIAL OFFICER2024-05-0210,000$36.05
$360.50kBuy

1 of 10

BPMC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BPMC insiders and whales buy or sell their stock.

BPMC Shareholders

What type of owners hold Blueprint Medicines Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.30%6,447,461$676.73MInstitution
Vanguard Group Inc10.08%6,309,977$662.30MInstitution
Price T Rowe Associates Inc9.98%6,250,823$656.09MInstitution
Kevin P. Starr8.71%5,453,753$572.43MInsider
Fmr LLC8.26%5,169,517$542.59MInstitution
Wellington Management Group LLP6.67%4,175,152$438.22MInstitution
Fmr LLC6.49%4,062,040$426.35MInsider
Mark J. Levin5.69%3,564,997$374.18MInsider
Rock Springs Capital Management LP3.99%2,498,448$262.24MInstitution
State Street Corp3.50%2,192,702$230.15MInstitution

1 of 3

BPMC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BPMC81.85%18.15%Net SellingNet Selling
RVMD89.67%10.33%Net SellingNet Selling
CYTK88.53%11.47%Net SellingNet Selling
JAZZ27.81%72.19%Net SellingNet Selling
EXEL85.17%4.18%Net SellingNet Selling

Blueprint Medicines Stock Ownership FAQ

Who owns Blueprint Medicines?

Blueprint Medicines (NASDAQ: BPMC) is owned by 103.85% institutional shareholders, 23.02% Blueprint Medicines insiders, and 0.00% retail investors. Kevin P. Starr is the largest individual Blueprint Medicines shareholder, owning 5.45M shares representing 8.71% of the company. Kevin P. Starr's Blueprint Medicines shares are currently valued at $568.61M.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.